Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Aug 19:2018:7328057.
doi: 10.1155/2018/7328057. eCollection 2018.

Response to: Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease"

Stefano Bibbò  1 , Maria Pina Dore  1 , Giovanni Cammarota  2
Affiliations
Comment

Response to: Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease"

Stefano Bibbò et al. Mediators Inflamm. .
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Li X., Yuan F. L. Comment on “Gut microbiota as a driver of inflammation in nonalcoholic fatty liver disease”. Mediators of Inflammation. 2018;2018:2. doi: 10.1155/2018/3746509.3746509 - DOI - PMC - PubMed
    1. Bibbò S., Ianiro G., Dore M. P., et al. Gut microbiota as a driver of inflammation in nonalcoholic fatty liver disease. Mediators of Inflammation. 2018;2018:7. doi: 10.1155/2018/9321643.9321643 - DOI - PMC - PubMed
    1. Kobyliak N., Abenavoli L., Mykhalchyshyn G., et al. A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial. Journal of Gastrointestinal and Liver Diseases. 2018;27(1):41–49. doi: 10.15403/jgld.2014.1121.271.kby. - DOI - PubMed
    1. Manzhalii E., Virchenko O., Falalyeyeva T., Beregova T., Stremmel W. Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: a pilot trial. Journal of Digestive Diseases. 2017;18(12):698–703. doi: 10.1111/1751-2980.12561. - DOI - PubMed
    1. Mofidi F., Poustchi H., Yari Z., et al. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. British Journal of Nutrition. 2017;117(5):662–668. doi: 10.1017/S0007114517000204. - DOI - PubMed

LinkOut - more resources